u 74006f has been researched along with Idiopathic Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Björklund, L; Spenger, C; Strömberg, I | 1 |
| Björklund, A; Brooks, DJ; Brundin, P; Crabb, L; Gustavii, B; Hagell, P; Kupsch, A; Lindvall, O; Marsden, CD; Odin, P; Oertel, WH; Piccini, P; Pogarell, O; Quinn, NP; Rehncrona, S; Schrag, A; Widner, H | 1 |
1 trial(s) available for u 74006f and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease.
Topics: Adult; Aged; Antiparkinson Agents; Brain Tissue Transplantation; Caudate Nucleus; Dopamine; Female; Fetal Tissue Transplantation; Follow-Up Studies; Graft Survival; Humans; Levodopa; Male; Mesencephalon; Middle Aged; Neuroprotective Agents; Parkinson Disease; Pregnatrienes; Putamen; Tomography, Emission-Computed | 2000 |
1 other study(ies) available for u 74006f and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Tirilazad mesylate increases dopaminergic neuronal survival in the in Oculo grafting model.
Topics: Animals; Anterior Chamber; Antioxidants; Brain Tissue Transplantation; Dopamine; Dose-Response Relationship, Drug; Fetal Tissue Transplantation; Graft Survival; Mesencephalon; Nerve Fibers; Neurons; Parkinson Disease; Pregnatrienes; Rats; Rats, Sprague-Dawley; Transplantation, Heterotopic | 1997 |